[go: up one dir, main page]

DK0871453T3 - Farmaceutisk kombinationspræparat til hormonal kontraception - Google Patents

Farmaceutisk kombinationspræparat til hormonal kontraception

Info

Publication number
DK0871453T3
DK0871453T3 DK96913497T DK96913497T DK0871453T3 DK 0871453 T3 DK0871453 T3 DK 0871453T3 DK 96913497 T DK96913497 T DK 96913497T DK 96913497 T DK96913497 T DK 96913497T DK 0871453 T3 DK0871453 T3 DK 0871453T3
Authority
DK
Denmark
Prior art keywords
hormone
pct
active ingredient
preparation
days
Prior art date
Application number
DK96913497T
Other languages
Danish (da)
English (en)
Inventor
Juergen Spona
Bernd Duesterberg
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7759440&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0871453(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK0871453T3 publication Critical patent/DK0871453T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK96913497T 1995-04-08 1996-04-04 Farmaceutisk kombinationspræparat til hormonal kontraception DK0871453T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19513662A DE19513662A1 (de) 1995-04-08 1995-04-08 Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
PCT/EP1996/001529 WO1996032114A1 (fr) 1995-04-08 1996-04-04 Preparation pharmaceutique combinee de contraception hormonale

Publications (1)

Publication Number Publication Date
DK0871453T3 true DK0871453T3 (da) 2003-09-15

Family

ID=7759440

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96913497T DK0871453T3 (da) 1995-04-08 1996-04-04 Farmaceutisk kombinationspræparat til hormonal kontraception

Country Status (16)

Country Link
US (1) US5980940A (fr)
EP (1) EP0871453B1 (fr)
JP (1) JPH11503440A (fr)
KR (1) KR19980703702A (fr)
CN (1) CN1077430C (fr)
AT (1) ATE240735T1 (fr)
AU (1) AU713771B2 (fr)
CA (1) CA2217564A1 (fr)
DE (2) DE19513662A1 (fr)
DK (1) DK0871453T3 (fr)
ES (1) ES2200062T3 (fr)
NO (1) NO313269B1 (fr)
NZ (1) NZ307178A (fr)
PT (1) PT871453E (fr)
RU (1) RU2165259C2 (fr)
WO (1) WO1996032114A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214815B1 (en) * 1998-12-23 2001-04-10 Ortho-Mcneil Pharmaceuticals, Inc. Triphasic oral contraceptive
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
IL148185A0 (en) * 1999-09-23 2002-09-12 Zentaris Ag Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
DE10100911A1 (de) * 2001-01-11 2002-08-01 Schering Ag Verfahren zur Hormonersatztherapie und dessen Darreichungsform
SI1453521T1 (sl) * 2001-12-05 2013-11-29 Teva Women's Health, Inc. Oralni kontraceptiki za preprečevanje nosečnosti in zmanjševanje predmenstrualne simptomatike
BR0313921A (pt) * 2002-08-28 2005-07-19 Gideon Kopernik Regime de reposição de estrogênio
CA2771944A1 (fr) * 2003-07-16 2005-01-27 Teva Women's Health, Inc. Procedes de traitement hormonal utilisant des posologies contraceptives avec administration continue d'oestrogenes
KR20060129175A (ko) * 2003-10-01 2006-12-15 얀센 파마슈티카 엔.브이. 확장된 3상 피임 요법
US20070111975A1 (en) 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
US20070077269A1 (en) * 2005-10-04 2007-04-05 Woodward John R Method of birth control and hormone regulation
WO2010042612A1 (fr) 2008-10-08 2010-04-15 Agile Therapeutics, Inc. Délivrance transdermique
EP2343964A4 (fr) 2008-10-08 2012-11-07 Agile Therapeutics Inc Administration transdermique
ES2734510T3 (es) 2008-10-08 2019-12-10 Agile Therapeutics Inc Administración transdérmica
EP2410859A4 (fr) 2009-03-27 2013-03-13 Agile Therapeutics Inc Administration transdermique
EP2880598A4 (fr) * 2012-07-31 2016-03-09 Univ New York Technique anti-contrefaçon par l'intermédiaire d'attributs

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6615481A (fr) * 1966-11-02 1968-05-03
AU4168068A (en) * 1969-07-22 1971-01-28 Unisearch Limited Improvements in or relating to oral contraceptives
US4921843A (en) * 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
GB8413070D0 (en) * 1984-05-22 1984-06-27 Mortimer C H Treatment of hair loss
FR2589735A1 (fr) * 1985-11-07 1987-05-15 Beillon Xavier Compositions anticonceptionnelles contenant un oestrogene et un progestatif
US5122382A (en) * 1990-10-29 1992-06-16 Alza Corporation Transdermal contraceptive formulations, methods and devices
DE4104385C1 (fr) * 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich
NL9301562A (nl) * 1993-09-09 1995-04-03 Saturnus Ag Preparaat voor substitutietherapie.
WO1995008329A1 (fr) * 1993-09-23 1995-03-30 Ortho Pharmaceutical Corporation Procedes de reduction du ldl cholesterol post-menopausique
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
DE4344405C2 (de) * 1993-12-24 1995-12-07 Marika Dr Med Ehrlich Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption
DE4411585A1 (de) * 1994-03-30 1995-10-05 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE4429374C1 (de) * 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
RU2091019C1 (ru) * 1996-01-15 1997-09-27 Валентина Александровна Андрюшина Контрацептивное средство для животных и способ его получения

Also Published As

Publication number Publication date
NO974630D0 (no) 1997-10-07
NO974630L (no) 1997-12-05
WO1996032114A1 (fr) 1996-10-17
US5980940A (en) 1999-11-09
PT871453E (pt) 2003-10-31
DE59610462D1 (de) 2003-06-26
DE19513662A1 (de) 1996-10-10
ES2200062T3 (es) 2004-03-01
CA2217564A1 (fr) 1996-10-17
NO313269B1 (no) 2002-09-09
EP0871453B1 (fr) 2003-05-21
NZ307178A (en) 2000-01-28
AU5646296A (en) 1996-10-30
RU2165259C2 (ru) 2001-04-20
CN1077430C (zh) 2002-01-09
KR19980703702A (ko) 1998-12-05
CN1181011A (zh) 1998-05-06
JPH11503440A (ja) 1999-03-26
ATE240735T1 (de) 2003-06-15
EP0871453A1 (fr) 1998-10-21
AU713771B2 (en) 1999-12-09

Similar Documents

Publication Publication Date Title
DK0750501T3 (da) Farmaceutisk kombinationspræparat til hormonal kontraception
NO976067L (no) Farmasöytisk kombinasjonspreparat, sett og fremgangsmåte for hormonell prevensjon
US4425339A (en) Treatment of menopausal symptoms
DK0871453T3 (da) Farmaceutisk kombinationspræparat til hormonal kontraception
KR960706344A (ko) 호르몬 피임 및/또는 여드름 치료 수단 및 방법(means and method for hormonal contraception and/or the treatment of acne)
ATE136781T1 (de) Ovulationshemmendes mittel zur hormonalen kontrazeption
KR20070004919A (ko) 연장된 호르몬성 피임제 투약법에서 파탄성 출혈의 관리
Benagiano et al. Seventy‐five microgram desogestrel minipill, a new perspective in estrogen‐free contraception
WO1994002103A3 (fr) Agent anti-ovulatoire de contraception hormonale
Koetsawang et al. Multicenter trial of two monophasic oral contraceptives containing 30 mcg ethinylestradiol and either desogestrel or gestodene in Thai women
JP4908399B2 (ja) 天然エストロゲンに基づく段階型避妊製剤
CA2248841A1 (fr) Combinaison sequentielle oestrogene/antagoniste de la progesterone s'utilisant en therapie hormonale de substitution